{"id":55910,"date":"2023-04-17T21:06:41","date_gmt":"2023-04-17T19:06:41","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/dyve-announces-poster-presentation-at-2023-aacr-annual-meeting\/"},"modified":"2023-04-17T21:06:41","modified_gmt":"2023-04-17T19:06:41","slug":"dyve-announces-poster-presentation-at-2023-aacr-annual-meeting","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/dyve-announces-poster-presentation-at-2023-aacr-annual-meeting\/","title":{"rendered":"Dyve Announces Poster Presentation at 2023 AACR Annual Meeting"},"content":{"rendered":"
\n

CAMARILLO, Calif.–(BUSINESS WIRE)–#biotechnology<\/a>—Dyve Biosciences<\/a>, Inc. (\u201cDyve\u201d), a clinical-stage platform biotechnology company with assets in immunology and oncology, today announced that preliminary data from the ongoing pre-clinical partnership with the H. Lee Moffitt Cancer Center & Research Institute<\/a> will be presented at a poster presentation at the upcoming American Association for Cancer Research<\/a> (AACR) annual meeting, taking place April 14-19, 2023, in Orlando, Florida.<\/p>\n

<\/a><\/p>\n

\nDyve will present pre-clinical data from its lead oncology drug candidate, DYV800, a pH modulating agent that targets tumor microenvironment (TME) acidity in solid tumors. DYV800, delivered topically to bypass gastrointestinal absorption challenges, neutralizes the TME acidity that plays a strong role in tumor progression (invasion, metastasis, angiogenesis), immune escape, and treatment resistance (radiation, chemotherapy, and immunotherapy).<\/p>\n

\n\u201cDyve continues to advance research in areas where we believe our pH modulation program can achieve the biggest impact for patients and we look forward to sharing new pre-clinical data on our DYV800 program at this year\u2019s AACR. We believe we have a unique delivery approach that can unlock the powerful effects of neutralizing TME acidity, and this dataset is further validation of that,\u201d said Ryan Beal, M.D.<\/a>, Chief Executive Officer, Dyve.<\/p>\n

\nPoster Presentation Details:<\/b><\/p>\n

\nAbstract Title:<\/b> Transdermal alkalinization treatment induces pH changes in a murine melanoma model as measured with MRI-CEST pH imaging
\n
Session Category:<\/b> Tumor Biology
\n
Session Title:<\/b> Photoacoustic Ultrasound, and Fluorescence Imaging
\n
Session Date and Time:<\/b> Monday, April 17, 2023, 1:30 PM – 5:00 PM
\n
Presenter:<\/b> Dr. Pietro Irrera, H. Lee Moffitt Cancer Center & Research Institute
\n
Location:<\/b> Convention Center, Section 2, Poster Board 13
\n
Abstract Presentation Number:<\/b> 2391<\/p>\n

\nAbout Dyve Biosciences, Inc.<\/b><\/p>\n

\nDyve Biosciences (\u201cDyve\u201d) is a clinically validated biotech that is breaking barriers to deliver on the promise of pH modulation. Decades of published research demonstrate that neutralizing microenvironment acidity profoundly impacts disease, with multi-fold improvements in tumor metastases, cancer survival, and immune response. Leveraging our groundbreaking DMAX delivery platform, Dyve\u2019s science directly targets the acidic microenvironments that drive cancer cell growth and inflammation. Dyve has demonstrated that it can deliver intuitive, targeted pH modulation to treat oncologic and immuno-inflammatory diseases. Learn more at www.dyvebio.com<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nCorporate & Investor Contact<\/b>
Jim McGee<\/a>
Dyve Biosciences, Inc.
\n
833-398-3246
\n
jim.mcgee@dyvebio.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

CAMARILLO, Calif.–(BUSINESS WIRE)–#biotechnology—Dyve Biosciences, Inc. (\u201cDyve\u201d), a clinical-stage platform biotechnology company with assets in immunology and oncology, today announced that preliminary data from the ongoing pre-clinical partnership with the H. Lee Moffitt Cancer Center & Research Institute will be presented at a poster presentation at the upcoming American Association for Cancer Research (AACR) annual meeting, … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55910","6":"format-standard","7":"category-industry"},"yoast_head":"\nDyve Announces Poster Presentation at 2023 AACR Annual Meeting - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/dyve-announces-poster-presentation-at-2023-aacr-annual-meeting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dyve Announces Poster Presentation at 2023 AACR Annual Meeting - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CAMARILLO, Calif.–(BUSINESS WIRE)–#biotechnology—Dyve Biosciences, Inc. (\u201cDyve\u201d), a clinical-stage platform biotechnology company with assets in immunology and oncology, today announced that preliminary data from the ongoing pre-clinical partnership with the H. Lee Moffitt Cancer Center & Research Institute will be presented at a poster presentation at the upcoming American Association for Cancer Research (AACR) annual meeting, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/dyve-announces-poster-presentation-at-2023-aacr-annual-meeting\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-17T19:06:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230417005780\/en\/1765755\/21\/Dyve_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dyve-announces-poster-presentation-at-2023-aacr-annual-meeting\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dyve-announces-poster-presentation-at-2023-aacr-annual-meeting\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Dyve Announces Poster Presentation at 2023 AACR Annual Meeting\",\"datePublished\":\"2023-04-17T19:06:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dyve-announces-poster-presentation-at-2023-aacr-annual-meeting\\\/\"},\"wordCount\":375,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dyve-announces-poster-presentation-at-2023-aacr-annual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230417005780\\\/en\\\/1765755\\\/21\\\/Dyve_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dyve-announces-poster-presentation-at-2023-aacr-annual-meeting\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dyve-announces-poster-presentation-at-2023-aacr-annual-meeting\\\/\",\"name\":\"Dyve Announces Poster Presentation at 2023 AACR Annual Meeting - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dyve-announces-poster-presentation-at-2023-aacr-annual-meeting\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dyve-announces-poster-presentation-at-2023-aacr-annual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230417005780\\\/en\\\/1765755\\\/21\\\/Dyve_Logo.jpg\",\"datePublished\":\"2023-04-17T19:06:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dyve-announces-poster-presentation-at-2023-aacr-annual-meeting\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dyve-announces-poster-presentation-at-2023-aacr-annual-meeting\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dyve-announces-poster-presentation-at-2023-aacr-annual-meeting\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230417005780\\\/en\\\/1765755\\\/21\\\/Dyve_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230417005780\\\/en\\\/1765755\\\/21\\\/Dyve_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dyve-announces-poster-presentation-at-2023-aacr-annual-meeting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dyve Announces Poster Presentation at 2023 AACR Annual Meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dyve Announces Poster Presentation at 2023 AACR Annual Meeting - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/dyve-announces-poster-presentation-at-2023-aacr-annual-meeting\/","og_locale":"en_US","og_type":"article","og_title":"Dyve Announces Poster Presentation at 2023 AACR Annual Meeting - Pharma Trend","og_description":"CAMARILLO, Calif.–(BUSINESS WIRE)–#biotechnology—Dyve Biosciences, Inc. (\u201cDyve\u201d), a clinical-stage platform biotechnology company with assets in immunology and oncology, today announced that preliminary data from the ongoing pre-clinical partnership with the H. Lee Moffitt Cancer Center & Research Institute will be presented at a poster presentation at the upcoming American Association for Cancer Research (AACR) annual meeting, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/dyve-announces-poster-presentation-at-2023-aacr-annual-meeting\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-17T19:06:41+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230417005780\/en\/1765755\/21\/Dyve_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/dyve-announces-poster-presentation-at-2023-aacr-annual-meeting\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/dyve-announces-poster-presentation-at-2023-aacr-annual-meeting\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Dyve Announces Poster Presentation at 2023 AACR Annual Meeting","datePublished":"2023-04-17T19:06:41+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/dyve-announces-poster-presentation-at-2023-aacr-annual-meeting\/"},"wordCount":375,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/dyve-announces-poster-presentation-at-2023-aacr-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230417005780\/en\/1765755\/21\/Dyve_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/dyve-announces-poster-presentation-at-2023-aacr-annual-meeting\/","url":"https:\/\/pharma-trend.com\/en\/dyve-announces-poster-presentation-at-2023-aacr-annual-meeting\/","name":"Dyve Announces Poster Presentation at 2023 AACR Annual Meeting - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/dyve-announces-poster-presentation-at-2023-aacr-annual-meeting\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/dyve-announces-poster-presentation-at-2023-aacr-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230417005780\/en\/1765755\/21\/Dyve_Logo.jpg","datePublished":"2023-04-17T19:06:41+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/dyve-announces-poster-presentation-at-2023-aacr-annual-meeting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/dyve-announces-poster-presentation-at-2023-aacr-annual-meeting\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/dyve-announces-poster-presentation-at-2023-aacr-annual-meeting\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230417005780\/en\/1765755\/21\/Dyve_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230417005780\/en\/1765755\/21\/Dyve_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/dyve-announces-poster-presentation-at-2023-aacr-annual-meeting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Dyve Announces Poster Presentation at 2023 AACR Annual Meeting"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55910","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55910"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55910\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55910"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55910"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55910"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}